ALNY is through a corrective pullback Right now it's in a position where it can go Bullish.
But it is what I call a weak buy demand because it's 50% of the peak where it started the reversal pullback. To buy from this position, I need to see a clear reversal pattern otherwise I´ll wait for it to continue the pullback and buy from the strong demand.
Alnylam Pharmaceuticals, Inc.
Long
Enter: 197.20
Take Profit: 214.49 (8.77%)
Stop Loss: 186.70
R:R Ratio: 1.65
Chart is bouncing of a parallel channel with a bullish candle
Based on our team's research of the options market, we expect buy activity at the support level or sell activity at the resistance. Although the amount of money involved is not large (less thatn 1 million dollars), the size of the option position is about 50% of the typical daily volume, indicating a substantial interest in breakpoints.
We primarily consider...
We see a successful breakout there and waiting for a retest of the descending trendline from December 22
And at this point after a successful retest price might hunt previous ATH
Entry point, SL, TP on chart GL
ALNY has been printing 2 corrective pattern separated waves and following an upper wicked shakeout reversal now appears to be entering a third wave that could potentially see a change up to become impulsive.
As we've seen many times now the fast wick up followed by impulsive downside is the BIG clue the trend is changing and also that it may become...
The PEAD projected a Bullish outlook for $ALNY after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 75%.
This one is for @tintin85, as I was just browsing through his list from supposed guru Mark Minervini.
ALNY has pumped hard on bad earnings and this I think is potentially a shakeout move before a fall.
ALNY has been in a long term ascending wedge for many years and this recent pump has gone from the lower to upper trendline in a day.
Also RSI divergence...
Price has broken the neckline.
Possible stop above neckline if short.
Possible targets in orange below price.
Price recovered from a prior large Head & Shoulders structure.
No recommendation
The PEAD projected a Bullish outlook for $ALNY after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 60%.
The biotech index looks sad so far. However, considering a specific stock, we have that we have bullish divergences, although not sure, the level, as well as the ema200 for the week.
From the fundamental one, you can attract interest in RNAi technology. Recently, DRNA was purchased with their platform, this company has its own, respectively, and the same areas of...
ALNY put in a new ATH as expected. A big bearish divergence played out after hitting the 1.618 fib extension plunging it all the way down to ~$155 and reaching oversold on the RSI. It resumed the uptrend as it followed a new trend line, which it broke as the S&P plunged on 3rd December. However, it seems to be recovering quickly and if it can break the important...
ALNY: Alnylam Pharmaceuticals, Inc.
2021-07-29 07:00:00
Alnylam Reports Positive Topline Results from ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1
ALNY is in a multi-year uptrend and it seems possible that a new ATH will be reached this year.
Bullish signs:
1) Bounce on the multi-year-trend-line (in black).
2) Trading above 20 + 50 EMA on daily, weekly and monthly.
3) Correction since january has reset the RSI.
4) Month of may forms a dragonfly doji.
What we'd like to see:
a) A higher high and a higher...
